Research & Article

COVID-19 Diagnostic Testing Policy Recommendations

ชื่อเรื่อง : COVID-19 Diagnostic Testing Policy Recommendations

(คำแนะนำเชิงนโยบายในการวินิจฉัย COVID-19)

หน่วยงาน : Infectious Diseases Society of America (IDSA)

เนื้อหาโดยย่อ : 

IDSA appreciates that HHS (including CDC and FDA), Congress, and laboratories (i.e. public health, commercial and academic) are working hard to expand testing capacity for COVID-19. Testing capacity, however, remains insufficient. IDSA recommends the following policies and investments to guarantee sufficient capacity for rapid, broad deployment of near-patient testing for this and future outbreaks. Inadequate access to testing (including delayed deployment of tests and slow turnaround time) severely limits our understanding of the prevalence, severity, mortality and transmission of respiratory viruses and negatively impacts patients, limits our ability to provide for their care and contain the spread of infection, and may cause unnecessary use of scarce resources such as negative pressure rooms and personal protective equipment (PPE).